Inventor · disambiguated record
Benjamin Oakes
Also filed as: OAKES BENJAMIN · OAKES BENJAMIN L
11 granted patents·22 pending applications·44 citations·filing 2014–2024
88Inventor score
Top patents by PatentIndex Score
33 records- 0194US11560555B2Engineered proteinsSCRIBE THERAPEUTICS INC·Filed 2021·Granted Jan 24, 2023·15 cites·25 claims
- 0293US12084692B2Guide scaffoldsSCRIBE THERAPEUTICS INC·Filed 2022·Granted Sep 10, 2024·5 cites·38 claims
- 0393US11535835B1Compositions and methods for the targeting of rhodopsinSCRIBE THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·7 cites·26 claims
- 0492US11613742B2Compositions and methods for the targeting of SOD1SCRIBE THERAPEUTICS INC·Filed 2021·Granted Mar 28, 2023·4 cites·25 claims
- 0591US12163125B2Engineered class 2 type V CRISPR systemsSCRIBE THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·5 cites·28 claims
- 0689US10494620B2Methods and compositions for modifying a single stranded target nucleic acidUNIV CALIFORNIA·Filed 2018·Granted Dec 3, 2019·3 cites·22 claims
- 0788US11976277B2Particle delivery systemsSCRIBE THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·3 cites·23 claims
- 0885US2025136962A1Catalytically dead engineered proteinsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0984US2025043262A1Gene editing pairsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1080US2025011756A1Methods of editing with engineered class 2 type v crispr systemsSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1176US9994831B2Methods and compositions for modifying a single stranded target nucleic acidUNIV CALIFORNIA·Filed 2014·Granted Jun 12, 2018·1 cites·10 claims
- 1274US2024101984A1Compositions and methods for the targeting of sod1SCRIBE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1374US2022220508A1Engineered casx systemsSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1470US2024026385A1Engineered class 2 type v crispr systemsSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1569US2020087642A1Methods and compositions for modifying a single stranded target nucleic acidUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1668US11008555B2Variant Cas9 polypeptides comprising internal insertionsUNIV CALIFORNIA·Filed 2016·Granted May 18, 2021·1 cites·14 claims
- 1764US2024392271A1Engineered casx repressor systemsSCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1864US2024360474A1Self-inactivating vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1963US2022348925A1Compositions and methods for the targeting of sod1SCRIBE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2062US12275964B2Variant type V CRISPR/Cas effector polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2019·Granted Apr 15, 2025·0 cites·23 claims
- 2161US2025361525A1Aav vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2260US2024309344A1COMPOSITIONS AND METHODS FOR THE TARGETING OF C9orf72SCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2360US2023033866A1Compositions and methods for the targeting of rhodopsinSCRIBE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2459US2023032369A1Compositions and methods for the targeting of httSCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2559US2025333767A1Engineered class 2 type v crispr systemsSCRIBE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2657US2024207196A1Compositions of glycoprotein particlesSCRIBE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2757US2022177872A1Deep mutational evolution of biomoleculesSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2857US2024026386A1Compositions and methods for the targeting of bcl11aSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2955US2024100185A1Compositions and methods for the targeting of ptbp1SCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3053US2023167424A1Compositions and methods for the targeting of pcsk9SCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3152US2024033377A1Aav vectors for gene editingSCRIBE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3249US2021269782A1Rna-guided effector proteins and methods of use thereofUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 3342US11180778B2Variant RNA-guided polypeptides and methods of useUNIV CALIFORNIA·Filed 2017·Granted Nov 23, 2021·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Benjamin Oakes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →